Searched for
LONZA
European shares rise on US-Japan trade deal, EU talks in focusEuropean stock markets saw gains, especially in the automobile sector. This followed positive signals from US President Donald Trump regard...- Flood risk threatens Swiss valley after village destroyed by glacierA massive landslide in southern Switzerland, triggered by glacial debris, buried the village of Blatten and blocked the River Lonza. The re...
- Switzerland Glacier collapse: Two more villages in danger of being wiped out, risk of floods loomsSwitzerland glacier collapse has left a quiet Alpine valley reeling, after a massive chunk of the Birch Glacier broke off and triggered a l...
- Maharashtra govt inks 54 MoUs of over Rs 15 lakh cr in two days at DavosMaharashtra signs 54 MoUs worth Rs 15.70 lakh crore at the World Economic Forum in Davos, with significant investments from Reliance Indust...
- Lupin enters CDMO business, names Abdelaziz Toumi as CEO of new subsidiaryLupin, a pharmaceutical company, has launched a new subsidiary named Lupin Manufacturing Solutions (LMS) to enter the Contract Development ...
- Lupin appoints Abdelaziz Toumi as CEO of newly formed armLupin Ltd appointed Abdelaziz Toumi as CEO of its new subsidiary, Lupin Manufacturing Solutions (LMS). Toumi, with over 20 years in biotech...
- Suven, with Cohance and more, wants to become a CDMO powerhouse: Annaswamy Vaidheesh, executive chairman"We want to be a diversified, end-to-end capability outsourcing partner, serving customers from development to commercial scale. Doing this...
- European shares slip as investors weigh earnings reportsShares of ASML Holding NV lost 2% and were among the top drags on the STOXX 600, despite forecasting sales growth of more than 25% for 2023.
- Switzerland warns of terror hits on vaccine infrastructure“Attacks on such targets would both hit large crowds and generate intensive media coverage,” the NDB spokesperson, Isabelle Graber, said in...
- AstraZeneca says antibody treatment failed in preventing COVID-19 in exposed patientsThe company said the participants in the trial were unvaccinated adults older than 18 years with confirmed exposure to a person with the co...
- Utilities, telecoms support European stocks; autos slideThe pan-European STOXX 600 index rose 0.2 per cent by 0713 GMT - holding below all-time highs - with sectors considered more stable such as...
- Moderna plans mix of COVID-19 vaccine doses with new Lonza dealIt has agreed a deal with Swiss-based drugmaker Lonza which said a new drug substance production line in Geleen, Netherlands, will have cap...
- Moderna CEO says world faces 2022 COVID vaccine production surplusSpeaking at a virtual event on vaccine manufacturing, Stephane Bancel said that additional technology transfers might dent their ability to...
- Swiss drugs regulator approves Moderna’s COVID-19 vaccineSwitzerland has been a second-wave coronavirus hotspot, with infections totalling some 500,000 and deaths rising by dozens daily to more th...
- Vaccine leader signs deal for 1 billion Covid-19 doses a yearModerna’s experimental shot induces the body’s own cells to make virus-like proteins that stimulate an immune response and prepare for an a...
- Luxury stocks sparkle in tepid European trading as US-China trade talks loomBritain's FTSE 100 jumped 0.9 per cent thanks to a weaker pound boosting London-listed multinational exporters.
- Sergio Marchionne, CEO who steered Fiat Chrysler, dies aged 66Marchionne, who described himself as a corporate fixer, was Fiat’s fifth CEO in less than two years when he took over.
- Telangana teams up with Cerestra to set up India’s first life sciences infra fundRao said the first of its kind fund will create sophisticated modular plug-and-play specialised infrastructure for pharmaceuticals, biotech...
- Salarpuria closes Bengaluru plot deal with US' Alexandria at a discountAlexandria Real Estate Equities, has separately sold Alexandria Knowledge Park at Genome Valley in Hyderabad for Rs 400 crore to Cerestra A...
- World's biggest maker of drug ingredients Lonza Group AG to buy Arch Chemicals for $1.2 billionLonza Group AG agreed to buy Arch Chemicals Inc. for $1.2 billion in cash to create the world's biggest microbial - control business.
Load More
